Invention Grant
- Patent Title: Tick octopamine receptor nucleic acid molecules
- Patent Title (中): 检查章鱼胺受体核酸分子
-
Application No.: US12200456Application Date: 2008-08-28
-
Publication No.: US07932371B2Publication Date: 2011-04-26
- Inventor: Kevin S. Brandt
- Applicant: Kevin S. Brandt
- Applicant Address: US CO Loveland
- Assignee: Heska Corporation
- Current Assignee: Heska Corporation
- Current Assignee Address: US CO Loveland
- Agency: Sheridan Ross P.C.
- Main IPC: C12N5/12
- IPC: C12N5/12 ; C12N15/63 ; C12N1/21 ; C12N1/15 ; C12N5/10 ; C07K14/705 ; G01N33/566
Abstract:
The present invention relates to tick octopamine receptor nucleic acid molecules; to tick octopamine receptor proteins encoded by such nucleic acid molecules; to antibodies raised against such proteins; and to compounds that inhibit the activity of such proteins. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. The present invention also includes inhibitory compounds, particularly those that specifically inhibit tick octopamine receptor activity, as well as the use of such compounds to treat animals.
Public/Granted literature
- US20090017494A1 TICK OCTOPAMINE RECEPTOR NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF Public/Granted day:2009-01-15
Information query
